Haleon plc (LON:HLN)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 29.75B -12.4% |
| Revenue (ttm) | 11.03B -1.8% |
| Net Income | 1.67B +15.6% |
| EPS | 0.19 +17.8% |
| Shares Out | 8.88B |
| PE Ratio | 18.11 |
| Forward PE | 16.31 |
| Dividend | 0.07 (2.17%) |
| Ex-Dividend Date | Apr 9, 2026 |
| Volume | 26,249,110 |
| Average Volume | 22,909,115 |
| Open | 325.60 |
| Previous Close | 327.10 |
| Day's Range | 325.00 - 335.00 |
| 52-Week Range | 274.40 - 419.50 |
| Beta | 0.25 |
| RSI | 37.65 |
| Earnings Date | Jul 30, 2026 |
About Haleon
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal dr... [Read more]
Full Company ProfileFinancial Performance
In 2025, Haleon's revenue was 11.03 billion, a decrease of -1.81% compared to the previous year's 11.23 billion. Earnings were 1.67 billion, an increase of 15.60%.
Financial StatementsNews
Centrum Launches Newly Reformulated Adults 50+ Complete Multivitamin with Clinically Shown Cognitive Benefits
New science-backed daily multivitamin specially formulated with essential vitamins and minerals to meet nutritional and health needs of older adults New science-backed daily multivitamin specially for...
Haleon price target lowered to 325 GBp from 350 GBp at Deutsche Bank
Deutsche Bank analyst Tom Sykes lowered the firm’s price target on Haleon (HLN) to 325 GBp from 350 GBp and keeps a Sell rating on the shares. Published first on
Haleon Earnings Call Transcript: Q1 2026
Q1 organic revenue grew 2.2%, led by strong oral health and innovation, despite weak cold and flu season and macro headwinds. Guidance for 3%-5% organic growth and high single-digit operating profit is maintained, with sequential improvement expected as North America, China, and Latin America accelerate.
Sensodyne maker Haleon reports organic revenue growth sligtly below estimates
British consumer healthcare group Haleon on Wednesday reported first quarter revenue growth slightly below analyst expectations, as weakness in other international markets offset growth in Nort...
Haleon launches ‘For the Assist’ campaign
Haleon (HLN), in partnership with the U.S. Soccer Federation, launched For the Assist, a new national campaign that celebrates the essential support that makes big goals possible-both on and off
Haleon Launches For the Assist Campaign in Partnership with the U.S. Soccer Federation Featuring Stars Tyler Adams and Crystal Dunn
WARREN, N.J.--(BUSINESS WIRE)--Today, Haleon, the consumer company that is solely focused on better everyday health, in partnership with the U.S. Soccer Federation, launched For the Assist, a new nati...
Brands Like Nestlé, Haleon, and Molson Coors Wrestle With Broken Measurement
Measuring the efficacy of ad spend continues to be one of the thorniest issues marketers face, and the frustrations bubbled up across multiple sessions during ADWEEK House at the Possible conference i...
Haleon appoints Richard Manso as U.S. CMO
Haleon (HLN) announced the appointment of Richard Manso as US Chief Marketing Officer. In this role, Manso will partner closely with CEO, US & President, North America Nathalie Gerschtein and
Haleon Appoints Richard Manso as US Chief Marketing Officer to Advance Data-driven, Consumer-centric Marketing in Delivering Better Everyday Health
WARREN, N.J.--(BUSINESS WIRE)--Today Haleon (NYSE: HLN), the consumer company that is solely focused on better everyday health, announced the appointment of Richard Manso as US Chief Marketing Officer...
Haleon price target raised to 512 GBp from 510 GBp at Berenberg
Berenberg raised the firm’s price target on Haleon (HLN) to 512 GBp from 510 GBp and keeps a Buy rating on the shares.
Haleon price target raised to 440 GBp from 420 GBp at Morgan Stanley
Morgan Stanley raised the firm’s price target on Haleon (HLN) to 440 GBp from 420 GBp and keeps an Overweight rating on the shares.
NEW parodontax Gum Strengthen & Protect Launches as a Daily Solution for Long-Term Gum Protection
WARREN, N.J.--(BUSINESS WIRE)--parodontax, the gum expert brand from Haleon, has launched NEW parodontax Gum Strengthen & Protect Toothpaste and Mouthwash with Hyaluronic Acid^, a daily oral care inno...
Haleon Strengthens Commitment to China as Consumers Focus on Better Everyday Health
SHANGHAI--(BUSINESS WIRE)-- #ConsumerHealth--Haleon, a consumer company that is solely focused on better everyday health, is investing £65 million in a new state-of-the-art oral health manufacturing s...
Haleon makes oral-health push in China as other Western brands falter
Haleon is stepping up its Chinese expansion, pushing into second- and third-tier cities and tailoring its gum-health products to local tastes, aiming to succeed where many Western consumer brands hav...
Study in Nature Medicine Finds Taking Centrum Silver Daily May Slow Biological Aging
WARREN, N.J.--(BUSINESS WIRE)--A new ancillary study published in Nature Medicine shows that Centrum Silver may slow biological aging markers. The findings come from an analysis of data from a randomi...
Haleon Earnings Call Transcript: H2 2025
Organic sales grew 3% in 2025, with strong gains in oral health and emerging markets, but U.S. and cold/flu categories lagged. Gross margin rose 220 bps, and 2026 guidance targets 3%-5% growth, supported by organizational changes and increased investment in A&P and R&D.
UK's Haleon reports slower fourth-quarter organic revenue growth
British consumer healthcare group Haleon reported a slowdown in fourth‑quarter revenue growth on Wednesday, as a delayed flu season hit sales of its respiratory-health products.
Haleon Earnings Call Transcript: H2 2025
Organic revenue grew 3% in 2025, with strong profit and cash flow despite weak category growth and consumer confidence. Oral health led segment gains, while North America and LATAM faced headwinds. 2026 guidance targets 3%-5% organic growth and high single-digit profit growth.
Haleon price target lowered to 510 GBp from 517 GBp at Berenberg
Berenberg lowered the firm’s price target on Haleon (HLN) to 510 GBp from 517 GBp and keeps a Buy rating on the shares.
New Sensodyne Clinical Repair Toothpaste Launches with Breakthrough Formula for Rapid, Clinically Proven Sensitivity Relief
WARREN, N.J.--(BUSINESS WIRE)--The No. 1 dentist-recommended brand for sensitive teeth has launched Sensodyne Clinical Repair, its newest option for sensitive teeth, a toothpaste designed to address t...
Haleon upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Warren Ackerman upgraded Haleon (HLN) to Overweight from Equal Weight with a price target of 420 GBp, up from 380 GBp. The firm adjusted ratings in the European
Haleon upgraded to Buy from Hold at HSBC
HSBC upgraded Haleon (HLN) to Buy from Hold with a 430 GBp price target
Haleon price target raised to 450 GBp from 440 GBp at Jefferies
Jefferies raised the firm’s price target on Haleon (HLN) to 450 GBp from 440 GBp and keeps a Buy rating on the shares after update estimates ahead of fiscal year
Haleon downgraded to Sell from Hold at Deutsche Bank
Deutsche Bank downgraded Haleon (HLN) to Sell from Hold with a 340 GBp price target The firm adjusted European consumer staples ratings as part of its 2026 outlook. Published first
TUMS Unveils Sweepstakes and Limited-Edition Burn Ball to Help Fans "Pass the TUMS" Ahead of Football's Big Game
Viral mega-creator Airrack joins the brand for a playful campaign featuring trick shots, social sweepstakes and heartburn relief that's passable WARREN, N.J., Jan. 6, 2026 /PRNewswire/ -- One in four ...